Shares of Carvana Co. (NYSE:CVNA) rose sharply in today's pre-market trading after the company reported better-than-expected second-quarter financial results.
Carvana reported second-quarter revenue of $3.41 billion, beating the consensus estimate of $3.244 billion, according to Benzinga Pro. The used car retailer reported quarterly earnings of 14 cents per share, beating analyst estimates for a loss of 12 cents per share.
Carvana shares jumped 13.4% to $151.12 in pre-market trading.
Here are some other stocks moving in pre-market trading.
Gainers
- FSD Pharma Inc. (NASDAQ:HUGE) gained 55.2% to $0.1568 in pre-market trading after falling 7% on Wednesday.
- Immuneering Corporation (NASDAQ:IMRX) gained 37.2% to $1.55 in pre-market trading after the company announced that IMM-1-104 was granted Fast Track designation from the FDA.
- CareDx, Inc (NASDAQ:CDNA) rose 23% to $24.58 in today's pre-market trading after the company reported better-than-expected second-quarter financial results.
- MediaAlpha, Inc. (NYSE:MAX) jumped 22.1% to $17.91 in pre-market trading after the company reported better-than-expected second-quarter financial results.
- Bone Biologics Corporation (NASDAQ:BBLG) shares gained 20.8% to $2.61 in pre-market trading after gaining 23% on Wednesday.
- Olo Inc. (NYSE:OLO) shares gained 19.1% to $5.69 in pre-market trading after the company reported better-than-expected second-quarter sales results.
- Sunnova Energy International Inc. (NYSE:NOVA) shares rose 17.5% to $8.31 in pre-market trading following upbeat quarterly results.
- Kaixin Holdings (NASDAQ:KXIN) shares gained 17.5% to $0.1308 in pre-market trading after the company announced it received a non-compliance notification from the Nasdaq.
- Rush Street Interactive, Inc. (NYSE RSI) shares rose 16.8% to $11.69 in pre-market trading after the company reported better-than-expected second-quarter earnings and raised FY24 revenue forecast.
Losers
- ALX Oncology Holdings Inc. (NASDAQ:ALXO) shares dipped 25.8% to $3.56 in pre-market trading. The company announced it will host an investor call and webcast to share topline data results from the Phase 2 ASPEN-06 clinical trial evaluating evorpacept for the treatment of advanced HER2-positive gastric cancer.
- noco-noco Inc. (NASDAQ:NCNC) shares fell 21.9% to $0.2240 in pre-market trading after jumping 88% on Wednesday.
- Alphatec Holdings, Inc. (NASDAQ:ATEC) shares declined 18.9% to $8.19 in pre-market trading after the company reported second-quarter results.
- Udemy, Inc. (NASDAQ:UDMY) fell 16.7% to $7.70 pre-market trading after the company reported mixed second-quarter financial results.
- Teladoc Health, Inc. (NYSE:TDOC) shares declined 16.3% to $7.89 in pre-market trading following weak quarterly sales results.
- Tenable Holdings, Inc. (NASDAQ:TENB) shares fell 14% to $39.51 in pre-market trading after the company reported second-quarter financial results.
- Standard Biotools Inc (NASDAQ:LAB) dipped 12.9% to $1.95 in pre-market trading after the company posted weak second-quarter results.
- Confluent, Inc. (NASDAQ:CFLT) shares declined 11.1% to $22.24 in pre-market trading after the company reported second-quarter financial results and issued third-quarter EPS guidance below estimates.
- Arm Holdings plc (NASDAQ:ARM) shares fell 9.6% to $130.28 in pre-market trading following weak second-quarter guidance.
- Western Digital Corporation (NASDAQ:WDC) fell 6.3% to $ 62.81 in today's pre-market trading after the company reported its fourth-quarter financial results.
Now Read This: